Who Paid My Doc
Karson Henry
Nurse Practitioner, Primary Care Benton, AR Nurse Practitioner
NPI 1316510043 CMS profile 10838001
824 Military Rd, Benton, AR 72015
General payments
$118
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Karson Henry of Benton, AR is reported in the CMS Open Payments database as having received $118 across 5 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 29th percentile of Nurse Practitioner, Primary Care profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $118 | 5 |
Beside peers
- Karson Henry
- Nurse Practitioner, Primary Care median
- Middle half of Nurse Practitioner, Primary Care
- National median
In program year 2025, general payments to Karson Henry were reported at $118. Among 4,814 Nurse Practitioner, Primary Care profiles paid that year, the median was $169 and the middle half received between $51 and $499.
Show as a table
| Year | Karson Henry | Nurse Practitioner, Primary Care median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $137 | $39–$445 | $132 |
| 2022 | $0 | $139 | $44–$421 | $149 |
| 2023 | $0 | $163 | $53–$481 | $160 |
| 2024 | $0 | $176 | $54–$511 | $164 |
| 2025 | $118 | $169 | $51–$499 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 21 drugsPart D claims
920
Drug cost
$8,614
Branded share of claims
12.7%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Fluticasone Propionate | Generic | 263 | $2,927 | |
| Albuterol Sulfate Hfa Albuterol Sulfate | Brand | 29 | $630 | |
| Doxycycline Hyclate | Generic | 63 | $625 | |
| Methylprednisolone | Generic | 86 | $553 | |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | Brand | 47 | $534 | |
| Azithromycin | Generic | 124 | $413 | |
| Oseltamivir Phosphate | Generic | 15 | $389 | |
| Valacyclovir Valacyclovir Hcl | Brand | 13 | $362 | |
| Clindamycin Hcl | Generic | 25 | $358 | |
| Mupirocin | Generic | 41 | $340 |
The 10 drugs with the highest cost, of 21 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 55 billing codesPaid by Medicare
$40,220
Medicare patients
359
Services billed
1,630
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 49% | |
| Ischemic heart disease | 33% | |
| Diabetes | 27% | |
| Depression | 27% | |
| Atrial fibrillation | 21% | |
| COPD | 16% | |
| Cancer | 14% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, dexamethasone sodium phosphate, 1 mg J1100 | Office | 47 | 436 | $31 |
| Injection, ketorolac tromethamine, per 15 mg J1885 | Office | 12 | 40 | $19 |
| Injection, ceftriaxone sodium, per 250 mg J0696 | Office | 14 | 60 | $17 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
5 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nurse Practitioner, Primary Care in Arkansas
Andrew Oliver
Nurse Practitioner, Primary Care · Maumelle, AR
Chelsea Presson
Nurse Practitioner, Primary Care · Little Rock, AR
Stephen Rohrer
Nurse Practitioner, Primary Care · Wynne, AR
Chelsea Marquis
Nurse Practitioner, Primary Care · Springdale, AR
Katherine Thompson
Nurse Practitioner, Primary Care · Little Rock, AR
Barbara Cole
Nurse Practitioner, Primary Care · North Little Rock, AR
Related records
Nurse Practitioner, Primary Care in Arkansas
Practitioners in the same specialty and state, ranked by reported value.
All Nurse Practitioner, Primary Care
Everyone recorded under this specialty, nationwide.
Doctors in Arkansas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.